Tazarotene Patent Expiration
Tazarotene is Used for treating acne vulgaris in patients 12 years of age or older. It was first introduced by Allergan Inc
Tazarotene Patents
Given below is the list of patents protecting Tazarotene, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Arazlo | US11311482 | Topical compositions and methods for treating skin diseases | May 11, 2038 | Bausch |
| Arazlo | US12128137 | Topical compositions and methods for treating skin diseases | May 11, 2038 | Bausch |
| Arazlo | US11679116 | Topical compositions and methods for treating psoriasis | Jun 06, 2036 | Bausch |
| Fabior | US10568859 | Topical foam composition | Feb 24, 2030 | Mayne Pharma |
| Fabior | US10688071 | Topical foam composition | Feb 24, 2030 | Mayne Pharma |
| Fabior | US8808716 | Topical foam composition | Feb 24, 2030 | Mayne Pharma |
| Arazlo | US6517847 | Topical gel delivery system |
Aug 03, 2020
(Expired) | Bausch |
| Tazorac | US5914334 | Stable gel formulation for topical treatment of skin conditions |
Jun 07, 2014
(Expired) | Allergan |
| Tazorac | US6258830 | Stable gel formulation for topical treatment of skin conditions |
Jun 07, 2014
(Expired) | Allergan |
Tazarotene's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List